In Vitro Drug Screening Using Ipsc-Derived Cardiomyocytes Of A Long Qt-Syndrome Patient Carrying Kcnq1 & Trpm4 Dual Mutation: An Experimental Personalized Treatment

Wang, F., Han, Y., Sang, W., Wang, L., Liang, X., Wang, L., Xing, Q., Guo, Y., Zhang, J., Zhang, L., Zukela, T., Xiaokereti, J., Lu, Y., Zhou, X. , Tang, B., and Li, Y. In Vitro Drug Screening Using Ipsc-Derived Cardiomyocytes Of A Long Qt-Syndrome Patient Carrying Kcnq1 & Trpm4 Dual Mutation: An Experimental Personalized Treatment. Cells. 2022, 11: 2495. Aug-22.